Statistics for Alliance Pharma PLC (id:3613 APH)

Valuation metrics

Market cap

251.90M

Enterprise value

342.94M

Trailing P/E (ttm)

-750.41

Forward P/E

0.09

PEG ratio

0.09

Price/Sales (ttm)

1.38

Price/Book (mrq)

113.11

Enterprise Value/Revenue

1.87

Enterprise Value/EBITDA

6.66

Overview

Shares outstanding

540.57M

Float

455.53M

Shares short

% Held by insiders

0.12%

% Held by institutions

0.69%

Average volume (10 days)

1.37M

Average volume (90 days)

Price summary

52-Week low

24.55

52-Week high

49.20

52-Week change

15.76%

Beta

0.64

50-Day moving average

43.51

200-Day moving average

38.90

Dividends and splits

Forward annual dividend rate

4.74

Forward annual dividend yield

0.10

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

2.18

Payout ratio

0.00

Dividend date

Ex-dividend date

June 22th, 2023

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-18.34%

Operating margin

17.02%

Operational effectiveness

Return on assets

5.98%

Return on equity

-13.44%

Income statement

Revenue (ttm)

0.34

Revenue per share (ttm)

0.34

Quarterly revenue growth (yoy)

-0.09

Gross profit (ttm)

105.02M

EBITDA

50.31M

Net income to common (ttm)

-33,582,000.00

Diluted EPS (ttm)

-0.06

Quarterly earnings growth (yoy)

-8.70%

Balance sheet

Total cash (mrq)

19.27M

Total cash per share (mrq)

0.04

Total debt (mrq)

105.79M

Total Debt/Equity (mrq)

47.46

Current ratio (mrq)

293.10%

Book value per share (mrq)

0.41

Cash flow

Cash flow statement

30.26M

Levered free cash flow (LFCF)

10.34M